Long-term survival in a patient with supratentorial glioblastoma: clinical considerations
- PMID: 10933461
- DOI: 10.1007/BF02427606
Long-term survival in a patient with supratentorial glioblastoma: clinical considerations
Abstract
Glioblastoma, a malignant tumor of neuroepithelial origin, is relatively uncommon in childhood, during which it accounts for 7%-9% of brain tumors. A few patients (about 3%) live more than 5 years. We report a 13-year-old girl who was admitted because one month earlier she had begun to present headache and diplopia. Brain computed tomography (CT) showed a right frontal tumor. At operation, complete excision of the visible tumor was performed. Histologic examination showed that the tumor was a glioblastoma multiforme. The patient underwent 52 Gy of external beam radiotherapy to the enhancing tumor mass plus 3-cm border, and chemotherapy with nitrosourea (BCNU). Fourteen years, 9 months later, the patient presents neither neurological deficits nor radiological relapse. We confirm that younger age, the one immutable prognostic factor, supports a particularly aggressive approach to the treatment of glioblastomas.
Similar articles
-
[Malignant progression of an anaplastic ganglioglioma into a glioblastoma multiforme--report on two cases and review of the literature].Khirurgiia (Sofiia). 2009;(2-3):69-74. Khirurgiia (Sofiia). 2009. PMID: 20506796 Bulgarian.
-
Clinical cure of glioblastoma--two case reports.Neurol Med Chir (Tokyo). 2000 Apr;40(4):224-9. doi: 10.2176/nmc.40.224. Neurol Med Chir (Tokyo). 2000. PMID: 10853323 Review.
-
Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period.Childs Nerv Syst. 1998 Jun;14(6):288-91. doi: 10.1007/s003810050228. Childs Nerv Syst. 1998. PMID: 9694343 Review.
-
Long-term survival in malignant glioma. Prognostic factors.J Fla Med Assoc. 1993 Mar;80(3):181-4. J Fla Med Assoc. 1993. PMID: 8387566
-
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).BMC Cancer. 2006 Oct 18;6:247. doi: 10.1186/1471-2407-6-247. BMC Cancer. 2006. PMID: 17049083 Free PMC article.
Cited by
-
Prognostic factors for long-term survival after glioblastoma.Perm J. 2008 Fall;12(4):45-8. doi: 10.7812/TPP/08-027. Perm J. 2008. PMID: 21339920 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Medical